Greece
- Department of Clinical Therapeutics
Durability, longevity, COVID-19, antibody, kinetics, SARS-CoV-2 variant, neutralization, anamnestic response, recall, re-exposure, Spike, Nucleocapsid, Spike-RBD, variants of concern, Alfa, Beta, Delta, Mu
MULTIPLE MYELOMA, dialysis-dependence, renal response, bortezomib-based treatment